| 摘要 |
FIELD: medicine.SUBSTANCE: venous blood and oral fluid are sampled from a patient in any sequence. An oral fluid biomarker is presented by carcino-embryonal antigen (CEA). A blood plasma biomarker is presented by neuron-specific enolase. If the oral fluid CEA is found in an amount of 196.8-318.4 ng/ml, while an amount of plasma neuron-specific enolase is 26.3-34.2 ng/ml, sarcoma of jaw bones is diagnosed. If the oral fluid CEA is found in an amount of 1228.2-1762 ng/ml with an amount of plasma neuron-specific enolase being 38.67-57.67 ng/ml, squamous cell carcinoma of jaw bones is diagnosed. The findings are used to predict a therapeutic approach to the patient.EFFECT: invention provides high-sensitive and accurate differential diagnostic technique of maxillary and mandibular malignant new growths on the day of visit to a doctor.2 cl, 6 ex |
